Subunit- and site-specific pharmacology of the NMDA receptor channel

Progress in Neurobiology

Volumn 59, Issue 3, 1999, Pages 279-298

  Yamakura, T ^a   Shimoji, K ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; HISTAMINE; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POLYAMINE; PROTEIN KINASE; RECEPTOR SUBUNIT;

BRAIN REGION; HUMAN; MEMORY; MOLECULAR CLONING; MOUSE; MUTANT; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN VARIANT; RECEPTOR BINDING; REVIEW; SYNAPSE;

ANIMALS; CALCIUM; EXCITATORY AMINO ACID AGONISTS; ION CHANNEL GATING; ION CHANNELS; MEMBRANE POTENTIALS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032790229     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(99)00007-6     Document Type: Review

References (268)

1. Aizenman E., Lipton S.A., Loring R.H. Selective modulation of NMDA responses by reduction and oxidation. Neuron. 2:1989;1257-1263.
2. Akazawa C., Shigemoto R., Bessho Y., Nakanishi S., Mizuno N. Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats. J. comp. Neurol. 347:1994;150-160.
3. Anantharam V., Panchal R.G., Wilson A., Kolchine V.V., Treistman S.N., Bayley H. Combinatorial RNA splicing alters the surface charge on the NMDA receptor. FEBS Lett. 305:1992;27-30.
4. Aniksztejn L., Otani S., Ben-Ari Y. Quisqualate metabotropic receptors modulate NMDA currents and facilitate induction of long-term potentiation through protein kinase C. Eur. J. Neurosci. 4:1992;500-505.
5. Anson L.C., Chen P.E., Wyllie D.J.A., Colquhoun D., Schoepfer R. Identification of amino acid residues of the NR2A subunit that control glutamate potency in recombinant NR1/NR2A NMDA receptors. J. Neurosci. 18:1998;581-589.
6. Ascher P., Nowak L. The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurones in culture. J. Physiol. (Lond.). 399:1988;247-266.
7. Asztely F., Gustafsson B. Ionotropic glutamate receptors. Their possible role in the expression of hippocampal synaptic plasticity. Mol. Neurobiol. 12:1996;1-11.
8. Avenet P., Leonardon J., Besnard F., Graham D., Depoortere H., Scatton B. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes. Neurosci. Lett. 223:1997;133-136.
9. Behe P., Stern P., Wyllie D.J., Nassar M., Schoepfer R., Colquhoun D. Determination of NMDA NR1 subunit copy number in recombinant NMDA receptors. Proc. R. Soc. Lond. B. 262:1995;205-213.
10. Bennett J.A., Dingledine R. Topology profile for a glutamate receptor: three transmembrane domains and a channel-lining reentrant membrane loop. Neuron. 14:1995;373-384.
11. Benveniste M., Mayer M.L. Multiple effects of spermine on N-methyl-D-aspartic acid receptor responses of rat cultured hippocampal neurones. J. Physiol. (Lond.). 464:1993;131-163.
12. Benveniste M., Clements J., Vyklicky L.J., Mayer M.L. A kinetic analysis of the modulation of N-methyl-D-aspartic acid receptors by glycine in mouse cultured hippocampal neurones. J. Physiol. (Lond.). 428:1990;333-357.
13. Bogden J.D., Troiano R.A., Joselow M.M. Copper, zinc, magnesium, and calcium in plasma and cerebrospinal fluid of patients with neurological diseases. Clin. Chem. 23:1977;485-489.
14. Brimecombe J.C., Boeckman F.A., Aizenman E. Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors. Proc. natl Acad. Sci. USA. 94:1997;11019-11024.
15. Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron. 8:1992;189-198.
16. Burnashev N., Schoepfer R., Monyer H., Ruppersberg J.P., Günther W., Seeburg P.H., Sakmann B. Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science. 257:1992;1415-1419.
17. Burnashev N., Zhou Z., Neher E., Sakmann B. Fractional calcium currents through recombinant GluR channels of the NMDA, AMPA and kainate receptor subtypes. J. Physiol. (Lond.). 485:1995;403-418.
18. Carter C.J., Lloyd K.G., Zivkovic B., Scatton B. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. J. Pharmac. Exp. Ther. 253:1990;475-482.
19. Cerne R., Rusin K.I., Randic M. Enhancement of the N-methyl-D-aspartate response in spinal dorsal horn neurons by cAMP-dependent protein kinase. Neurosci. Lett. 161:1993;124-128.
20. 1-(n-octanesulfonyl)-spermine, novel glutamate receptor antagonists: block and permeation of N-methyl-D-aspartate receptors. Mol. Pharmac. 51:1997;861-871.
21. Chazot P.L., Cik M., Stephenson F.A. Immunological detection of the NMDAR1 glutamate receptor subunit expressed in embryonic kidney 293 cells and in rat brain. J. Neurochem. 59:1992;1176-1178.
22. Chazot P.L., Coleman S.K., Cik M., Stephenson F.A. Molecular characterization of N-methyl-D-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule. J. biol. Chem. 269:1994;24403-24409.
23. Chen C., Leonard J.P. Protein tyrosine kinase-mediated potentiation of currents from cloned NMDA receptors. J. Neurochem. 67:1996;194-200.
24. Chen H.-S.V., Lipton S.A. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J. Physiol. (Lond.). 499:1997;27-46.
25. Chen L., Huang L.Y. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid. Neuron. 7:1991;319-326.
26. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature. 356:1992;521-523.
27. Chen N., Moshaver A., Raymond L.A. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition. Mol. Pharmac. 51:1997;1015-1023.
28. Choi D.W. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18:1995;58-60.
29. Christine C.W., Choi D.W. Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons. J. Neurosci. 10:1990;108-116.
30. Ciabarra A.M., Sullivan J.M., Gahn L.G., Pecht G., Heinemann S., Sevarino K.A. Cloning and characterization of χ-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J. Neurosci. 15:1995;6498-6508.
31. Das S., Sasaki Y.F., Rothe T., Premkumar L.S., Takasu M., Crandall J.E., Dikkes P., Conner D.A., Rayudu P.V., Cheung W., Chen H.S., Lipton S.A., Nakanishi N. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature. 393:1998;377-381.
32. Durand G.M., Gregor P., Zheng X., Bennett M.V., Uhl G.R., Zukin R.S. Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C. Proc. Natl Acad. Sci. USA. 89:1992;9359-9363.
33. Durand G.M., Bennett M.V., Zukin R.S. Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C. Proc. Natl Acad. Sci. USA. 90:1993;6731-6735.
34. Ebralidze A.K., Rossi D.J., Tonegawa S., Slater N.T. Modification of NMDA receptor channels and synaptic transmission by targeted disruption of the NR2C gene. J. Neurosci. 16:1996;5014-5025.
35. Ehlers M.D., Tingley W.G., Huganir R.L. Regulated subcellular distribution of the NR1 subunit of the NMDA receptor. Science. 269:1995;1734-1737.
36. Ehlers M.D., Zhang S., Bernhadt J.P., Huganir R.L. Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit. Cell. 84:1996;745-755.
37. Ehlers M.D., Fung E.T., O'Brien R.J., Huganir R.L. Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments. J. Neurosci. 18:1998;720-730.
38. Fage D., Voltz C., Scatton B., Carter C. Selective release of spermine and spermidine from the rat striatum by N-methyl-D-aspartate receptor activation in vivo. J. Neurochem. 58:1992;2170-2175.
39. Fagni L., Olivier M., Lafon-Cazal M., Bockaert J. Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells. Mol. Pharmac. 47:1995;1239-1247.
40. Ferrer-Montiel A.V., Montal M. Pentameric subunit stoichiometry of a neuronal glutamate receptor. Proc. Natl Acad. Sci. USA. 93:1996;2741-2744.
41. Ferrer-Montiel A.V., Sun W., Montal M. Molecular design of the N-methyl-D-aspartate receptor binding site for phencyclidine and dizocilpine. Proc. Natl Acad. Sci. USA. 92:1995;8021-8025.
42. Fischer G., Mutel V., Trube G., Malherbe P., Kew J.N., Mohacsi E., Heitz M.P., Kemp J.A. Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. J. Pharmac. Exp. Ther. 283:1997;1285-1292.
43. Forrest D., Yuzaki M., Soares H.D., Ng L., Luk D.C., Sheng M., Stewart C.L., Morgan J.I., Connor J.A., Curran T. Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron. 13:1994;325-338.
44. Franks N.P., Dickinson R., de Sousa S.L.M., Hall A.C., Lieb W.R. How does xenon produce anaesthesia? Nature. 396:1998;324.
45. Gallagher M.J., Huang H., Pritchett D.B., Lynch D.R. Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor. J. biol. Chem. 271:1996;9603-9611.
46. Gallagher M.J., Huang H., Grant E.R., Lynch D.R. The NR2B-specific interactions of polyamines and protons with the N-methyl-D-aspartate receptor. J. biol. Chem. 272:1997;24971-24979.
47. Gallagher M.J., Huang H., Lynch D.R. Modulation of the N-methyl-D-aspartate receptor by haloperidol: NR2B-specific interactions. J. Neurochem. 70:1998;2120-2128.
48. Gerber G., Kangrga I., Ryu P.D., Larew J.S., Randic M. Multiple effects of phorbol esters in the rat spinal dorsal horn. J. Neurosci. 9:1989;3606-3617.
49. Gozlan H., Ben-Ari Y. NMDA receptor redox sites: are they targets for selective neuronal protection? Trends Pharmac. Sci. 16:1995;368-374.
50. Grimwood S., Le Bourdelles B., Whiting P.J. Recombinant human NMDA homomeric NR1 receptors expressed in mammalian cells form a high-affinity glycine antagonist binding site. J. Neurochem. 64:1995;525-530.
51. Hall R.A., Soderling T.R. Differential surface expression and phosphorylation of the N-methyl-D-aspartate receptor subunits NR1 and NR2 in cultured hippocampal neurons. J. biol. Chem. 272:1997;4135-4140.
52. Harman R.J., Shaw G.G. High-affinity uptake of spermine by slices of rat cerebral cortex. J. Neurochem. 36:1981;1609-1615.
53. Harman R.J., Shaw G.G. The spontaneous and evoked release of spermine from rat brain in vitro. Br. J. Pharmac. 73:1981;165-174.
54. Harris R.A., Mihic S.J., Dildy-Mayfield J.E., Machu T.K. Actions of anesthetics on ligand-gated ion channels: role of receptor subunit composition. FASEB J. 9:1995;1454-1462.
55. Henley J.M., Ambrosini A., Rodriguez-Ithurralde D., Sudan H., Brackley P., Kerry C., Mellor I., Abutidze K., Usherwood P.N.R., Barnard E.A. Purified unitary kainate/α-amino-3-hydroxy-5-methylisooxazole-propionate (AMPA) and kainate/AMPA/N-methyl-D-aspartate receptors with interchangeable subunits. Proc. Natl Acad. Sci. USA. 89:1992;4806-4810.
56. Hirai H., Kirsch J., Laube B., Betz H., Kuhse J. The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region. Proc. Natl Acad. Sci. USA. 93:1996;6031-6036.
57. Hisatsune C., Umemori H., Inoue T., Michikawa T., Kohda K., Mikoshiba K., Yamamoto T. Phosphorylation-dependent regulation of N-methyl-D-aspartate receptors by calmodulin. J. biol. Chem. 272:1997;20805-20810.
58. Hollmann M., Heinemann S. Cloned glutamate receptors. A. Rev. Neurosci. 17:1994;31-108.
59. Hollmann M., Boulter J., Maron C., Beasley L., Sullivan J., Pecht G., Heinemann S. Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Neuron. 10:1993;943-954.
60. Hollmann M., Maron C., Heinemann S. N-glycosylation site tagging suggests a three transmembrane domain topology for the glutamate receptor GluR1. Neuron. 13:1994;1331-1343.
61. Horimoto N., Nabekura J., Ogawa T. Developmental changes in arachidonic acid potentiation of NMDA currents in cortical neurones. Neuroreport. 7:1996;2463-2467.
62. 2+ in cultured rat forebrain neurons. Brain Res. 592:1992;310-316.
63. Hume R.I., Dingledine R., Heinemann S.F. Identification of a site in glutamate receptor subunits that controls calcium permeability. Science. 253:1991;1028-1031.
64. Ikeda K., Nagasawa M., Mori H., Araki K., Sakimura K., Watanabe M., Inoue Y., Mishina M. Cloning and expression of the ε4 subunit of the NMDA receptor channel. FEBS Lett. 313:1992;34-38.
65. Ikeda K., Araki K., Takayama C., Inoue Y., Yagi T., Aizawa S., Mishina M. Reduced spontaneous activity of mice defective in the ε4 subunit of the NMDA receptor channel. Mol. Brain Res. 33:1995;61-71.
66. Ilyin V.I., Whittemore E.R., Guastella J., Weber E., Woodward R.M. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. Mol. Pharmac. 50:1996;1541-1550.
67. Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M., Akazawa C., Shigemoto R., Mizuno N., Masu M., Nakanishi S. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J. biol. Chem. 268:1993;2836-2843.
68. Ishimaru H., Kamboj R., Ambrosini A., Henley J.M., Soloviev M.M., Sudan H., Rossier J., Abutidze K., Rampersad V., Usherwood P.N., Bateson A.N., Barnard E.A. A unitary non-NMDA receptor short subunit from Xenopus: DNA cloning and expression. Receptors Channels. 4:1996;31-49.
69. Ito I., Futai K., Katagiri H., Watanabe M., Sakimura K., Mishina M., Sugiyama H. Synapse-selective impairment of NMDA receptor functions in mice lacking NMDA receptor ε1 or ε2 subunit. J. Physiol. (Lond.). 500:1997;401-408.
70. Jahr C.E., Stevens C.F. Calcium permeability of the N-methyl-D-aspartate receptor channel in hippocampal neurons in culture. Proc. Natl Acad. Sci. USA. 90:1993;11573-11577.
71. Javitt D.C., Zylberman I., Zukin S.R., Heresco-Levy U., Lindenmayer J.P. Amelioration of negative symptoms in schizophrenia by glycine. Am. J. Psychiatry. 151:1994;1234-1236.
72. Jevtovic-Todorovic V., Todorovic S.M., Mennerick S., Powell S., Dikranian K., Benshoff N., Zorumski C.F., Olney J.W. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nature Med. 4:1998;460-463.
73. 2+ of N-methyl-D-aspartate-activated channels. Biophys. J. 57:1990;1085-1090.
74. Johnson T.D. Modulation of channel function by polyamines. Trends Pharmac. Sci. 17:1996;22-27.
75. Kadotani H., Hirano T., Masugi M., Nakamura K., Nakao K., Katsuki M., Nakanishi S. Motor discoordination results from combined gene disruption of the NMDA receptor NR2A and NR2C subunits, but not from single disruption of the NR2A or NR2C subunit. J. Neurosci. 16:1996;7859-7867.
76. Kashiwagi K., Fukuchi J., Chao J., Igarashi K., Williams K. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons. Mol. Pharmac. 49:1996;1131-1141.
77. Kashiwagi K., Pahk A.J., Masuko T., Igarashi K., Williams K. Block and modulation of N-methyl-D-aspartate receptors by polyamines and protons: role of amino acid residues in the transmembrane and pore-forming regions of NR1 and NR2 subunits. Mol. Pharmac. 52:1997;701-713.
78. Kawajiri S., Dingledine R. Multiple structural determinants of voltage-dependent magnesium block in recombinant NMDA receptors. Neuropharmacology. 32:1993;1203-1211.
79. Kew J.N., Trube G., Kemp J.A. A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J. Physiol. (Lond.). 497:1996;761-772.
80. Kew J.N., Trube G., Kemp J.A. State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist. Br. J. Pharmac. 123:1998;463-472.
81. Kim E., Cho K.O., Rothschild A., Sheng M. Heteromultimerization and NMDA receptor-clustering activity of Chapsyn-110, a member of the PSD-95 family of proteins. Neuron. 17:1996;103-113.
82. Kiyama Y., Manabe T., Sakimura K., Kawakami F., Mori H., Mishina M. Increased thresholds for long-term potentiation and contextual learning in mice lacking the NMDA-type glutamate receptor ε1 subunit. J. Neurosci. 18:1998;6704-6712.
83. Koltchine V., Anantharam V., Wilson A., Bayley H., Treistman S.N. Homomeric assemblies of NMDAR1 splice variants are sensitive to ethanol. Neurosci. Lett. 152:1993;13-16.
84. Kornau H.C., Schenker L.T., Kennedy M.B., Seeburg P.H. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science. 269:1995;1737-1740.
85. Kornhuber J., Weller M. Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy. Biol. Psychiat. 41:1997;135-144.
86. Kornhuber J., Weller M., Schoppmeyer K., Riederer P. Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J. Neural Transm. 43:(Suppl.):1994;91-104.
87. Krupp J.J., Vissel B., Heinemann S.F., Westbrook G.L. Calcium-dependent inactivation of recombinant N-methyl-D-aspartate receptors is NR2 subunit specific. Mol. Pharmac. 50:1996;1680-1688.
88. Krupp J.J., Vissel B., Heinemann S.F., Westbrook G.L. N-terminal domains in the NR2 subunit control desensitization of NMDA receptors. Neuron. 20:1998;317-327.
89. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B. Jr., Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiat. 51:1994;199-214.
90. 2+ block in NMDA receptor channels. J. Neurosci. 16:1996;3549-3558.
91. Kuner T., Schoepfer R., Korpi E.R. Ethanol inhibits glutamate-induced currents in heteromeric NMDA receptor subtypes. Neuroreport. 5:1993;297-300.
92. Kuner T., Wollmuth L.P., Karlin A., Seeburg P.H., Sakmann B. Structure of the NMDA receptor channel M2 segment inferred from the accessibility of substituted cysteines. Neuron. 17:1996;343-352.
93. Kupper J., Ascher P., Neyton J. Probing the pore region of recombinant N-methyl-D-aspartate channels using external and internal magnesium block. Proc. Natl Acad. Sci. USA. 93:1996;8648-8653.
94. Kuryatov A., Laube B., Betz H., Kuhse J. Mutational analysis of the glycine-binding site of the NMDA receptor: structural similarity with bacterial amino acid-binding proteins. Neuron. 12:1994;1291-1300.
95. Kutsuwada T., Kashiwabuchi N., Mori H., Sakimura K., Kushiya E., Araki K., Meguro H., Masaki H., Kumanishi T., Arakawa M., Mishina M. Molecular diversity of the NMDA receptor channel. Nature. 358:1992;36-41.
96. Kutsuwada T., Sakimura K., Manabe T., Takayama C., Katakura N., Kushiya E., Natsume R., Watanabe M., Inoue Y., Yagi T., Aizawa S., Arakawa M., Takahashi T., Nakamura Y., Mori H., Mishina M. Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor ε2 subunit mutant mice. Neuron. 16:1996;333-344.
97. Köhr G., Seeburg P.H. Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family. J. Physiol. (Lond.). 492:1996;445-452.
98. Köhr G., Eckardt S., Luddens H., Monyer H., Seeburg P.H. NMDA receptor channels: subunit-specific potentiation by reducing agents. Neuron. 12:1994;1031-1040.
99. Kyrozis A., Goldstein P.A., Heath M.J., MacDermott A.B. Calcium entry through a subpopulation of AMPA receptors desensitized neighbouring NMDA receptors in rat dorsal horn neurons. J. Physiol. (Lond.). 485:1995;373-381.
100. Lau L.F., Huganir R.L. Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits. J. biol. Chem. 270:1995;20036-20041.
101. Laube B., Hirai H., Sturgess M., Betz H., Kuhse J. Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron. 18:1997;493-503.
102. Laurie D.J., Seeburg P.H. Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA. J. Neurosci. 14:1994;3180-3194.
103. Laurie D.J., Putzke J., Zieglgansberger W., Seeburg P.H., Tölle T.R. The distribution of splice variants of the NMDAR1 subunit mRNA in adult rat brain. Mol. Brain Res. 32:1995;94-108.
104. Legendre P., Westbrook G.L. The inhibition of single N-methyl-D-aspartate-activated channels by zinc ions on cultured rat neurones. J. Physiol. (Lond.). 429:1990;429-449.
105. Legendre P., Rosenmund C., Westbrook G.L. Inactivation of NMDA channels in cultured hippocampal neurons by intracellular calcium. J. Neurosci. 13:1993;674-684.
106. Lei S.Z., Pan Z.H., Aggarwal S.K., Chen H.S., Hartman J., Sucher N.J., Lipton S.A. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron. 8:1992;1087-1099.
107. Leonard A.S., Hell J.W. Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites. J. Biol. Chem. 272:1997;12107-12115.
108. Lerma J. Spermine regulates N-methyl-D-aspartate receptor desensitization. Neuron. 8:1992;343-352.
109. Lester R.A., Tong G., Jahr C.E. Interactions between the glycine and glutamate binding sites of the NMDA receptor. J. Neurosci. 13:1993;1088-1096.
110. Li Y., Erzurumlu R.S., Chen C., Jhaveri S., Tonegawa S. Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell. 76:1994;427-437.
111. 2+ of the NMDA-activated channel in cultured rat neurons. J. Physiol. (Lond.). 491:1996;121-135.
112. 2+-dependent phosphatase. Nature. 369:1994;235-239.
113. Lin L.H., Chen L.L., Harris R.A. Enflurane inhibits NMDA, AMPA, and kainate-induced currents in Xenopus oocytes expressing mouse and human brain mRNA. FASEB J. 7:1993;479-485.
114. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:1994;613-622.
115. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
116. Lipton S.A., Choi Y.B., Sucher N.J., Pan Z.H., Stamler J.S. Redox state, NMDA receptors and NO-related species. Trends Pharmac. Sci. 17:1996;186-187.
117. Luo J., Wang Y., Yasuda R.P., Dunah A.W., Wolfe B.B. The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol. Pharmac. 51:1997;79-86.
118. Lynch D.R., Gallagher M.J. Inhibition of N-methyl-D-aspartate receptors by haloperidol: developmental and pharmacological characterization in native and recombinant receptors. J. Pharmac. Exp. Ther. 279:1996;154-161.
119. Lynch D.R., Lawrence J.J., Lenz S., Anegawa N.J., Dichter M., Pritchett D.B. Pharmacological characterization of heterodimeric NMDA receptors composed of NR 1a and 2B subunits: differences with receptors formed from NR 1a and 2A. J. Neurochem. 64:1995;1462-1468.
120. MacDermott A.B., Mayer M.L., Westbrook G.L., Smith S.J., Barker J.L. NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature. 321:1986;519-522.
121. Manzoni O., Prezeau L., Marin P., Deshager S., Bockaert J., Fagni L. Nitric oxide-induced blockade of NMDA receptors. Neuron. 8:1992;653-662.
122. Markram H., Segal M. Activation of protein kinase C suppresses responses to NMDA in rat CA1 hippocampal neurones. J. Physiol. (Lond.). 457:1992;491-501.
123. Masood K., Wu C., Brauneis U., Weight F.F. Differential ethanol sensitivity of recombinant N-methyl-D-aspartate receptor subunits. Mol. Pharmac. 45:1994;324-329.
124. Mayer M.L., Westbrook G.L. The physiology of excitatory amino acids in the vertebrate central nervous system. Prog. Neurobiol. 28:1987;197-276.
125. 2+ of NMDA responses in spinal cord neurones. Nature. 309:1984;261-263.
126. Mayer M.L., Vyklicky L.J., Clements J. Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine. Nature. 338:1989;425-427.
127. Mayer M.L., Vyklicky L.J., Westbrook G.L. Modulation of excitatory amino acid receptors by group IIB metal cations in cultured mouse hippocampal neurones. J. Physiol. (Lond.). 415:1989;329-350.
128. McBain C.J., Mayer M.L. N-methyl-D-aspartic acid receptor structure and function. Physiol. Rev. 74:1994;723-760.
129. McHugh T.J., Blum K.I., Tsien J.Z., Tonegawa S., Wilson M.A. Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice. Cell. 87:1996;1339-1349.
130. Medina I., Filippova N., Charton G., Rougeole S., Ben-Ari Y., Khrestchatisky M., Bregestovski P. Calcium-dependent inactivation of heteromeric NMDA receptor-channels expressed in human embryonic kidney cells. J. Physiol. (Lond.). 482:1995;567-573.
131. Meguro H., Mori H., Araki K., Kushiya E., Kutsuwada T., Yamazaki M., Kumanishi T., Arakawa M., Sakimura K., Mishina M. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature. 357:1992;70-74.
132. Miller B., Sarantis M., Traynelis S.F., Attwell D. Potentiation of NMDA receptor currents by arachidonic acid. Nature. 355:1992;722-725.
133. Minami K., Wick M.J., Stern-Bach Y., Dildy-Mayfield J.E., Brozowski S.J., Gonzales E.L., Trudell J.R., Harris R.A. Sites of volatile anesthetic action on kainate (glutamate receptor 6) receptors. J. Biol. Chem. 273:1998;8248-8255.
134. 2+-insensitive mutants. Neuropharmacology. 34:1995;347-355.
135. 2+ permeability of AMPA-selective glutamate receptor channels. Biochem. Biophys. Res. Commun. 180:1991;813-821.
136. Mishina M., Mori H., Araki K., Kushiya E., Meguro H., Kutsuwada T., Kashiwabuchi N., Ikeda K., Nagasawa M., Yamazaki M., Masaki H., Yamakura T., Morita T., Sakimura K. Molecular and functional diversity of the NMDA receptor channel. Ann. N.Y. Acad. Sci. 707:1993;136-152.
137. Miyakawa T., Yagi T., Kitazawa H., Yasuda M., Kawai N., Tsuboi K., Niki H. Fyn-kinase as a determinant of ethanol sensitivity: relation to NMDA-receptor function. Science. 278:1997;698-701.
138. Monaghan D.T., Bridges R.J., Cotman C.W. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. A. Rev. Pharmac. Toxic. 29:1989;365-402.
139. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science. 256:1992;1217-1221.
140. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 12:1994;529-540.
141. Moon I.S., Apperson M.L., Kennedy M.B. The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-D-aspartate receptor subunit 2B. Proc. Natl Acad. Sci. USA. 91:1994;3954-3958.
142. Mori H., Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology. 34:1995;1219-1237.
143. 2+-block site of the NMDA receptor channel. Nature. 358:1992;673-675.
144. Mori H., Yamakura T., Masaki H., Mishina M. Involvement of the carboxyl-terminal region in modulation by TPA of the NMDA receptor channel. Neuroreport. 4:1993;519-522.
145. Mori H., Manabe T., Watanabe M., Satoh Y., Suzuki N., Toki S., Nakamura K., Yagi T., Kushiya E., Takahashi T., Inoue Y., Sakimura K., Mishina M. Role of the carboxyl-terminal region of the GluRε2 subunit in synaptic localization of the NMDA receptor channel. Neuron. 21:1998;571-580.
146. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature. 354:1991;31-37.
147. 3H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits. J. Neurochem. 70:1998;2147-2155.
148. Müller B.M., Kistner U., Kindler S., Chung W.J., Kuhlendahl S., Fenster S.D., Lau L.F., Veh R.W., Huganir R.L., Gundelfinger E.D., Garner C.C. SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in vivo. Neuron. 17:1996;255-265.
149. Nakanishi N., Axel R., Shneider N.A. Alternative splicing generates functionally distinct N-methyl-D-aspartate receptors. Proc. Natl Acad. Sci. USA. 89:1992;8552-8556.
150. Nakanishi S., Masu M. Molecular diversity and functions of glutamate receptors. A. Rev. Biophys. Biomol. Struct. 23:1994;319-348.
151. Niethammer M., Kim E., Sheng M. Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases. J. Neurosci. 16:1996;2157-2163.
152. Nowak L., Bregestovski P., Ascher P., Herbet A., Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature. 307:1984;462-465.
153. O'Hara P.J., Sheppard P.O., Thogersen H., Venezia D., Haldeman B.A., McGrane V., Houamed K.M., Thomsen C., Gilbert T.L., Mulvihill E.R. The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. Neuron. 11:1993;41-52.
154. Olney J.W. Neurotoxicity of NMDA receptor antagonists: an overview. Psychopharmac. Bull. 30:1994;533-540.
155. Omerovic A., Leonard J.P., Kelso S.R. Effects of nitroprusside and redox reagents on NMDA receptors expressed in Xenopus oocytes. Mol. Brain Res. 22:1994;89-96.
156. Omerovic A., Chen S.J., Leonard J.P., Kelso S.R. Subunit-specific redox modulation of NMDA receptors expressed in Xenopus oocytes. J. Recept. Signal Transduct. Res. 15:1995;811-827.
157. Omkumar R.V., Kiely M.J., Rosenstein A.J., Min K.T., Kennedy M.B. Identification of a phosphorylation site for calcium/calmodulin-dependent protein kinase II in the NR2B subunit of the N-methyl-D-aspartate receptor. J. Biol. Chem. 271:1996;31670-31678.
158. Ozawa S., Kamiya H., Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog. Neurobiol. 54:1998;581-618.
159. Pahk A.J., Williams K. Influence of extracellular pH on inhibition by ifenprodil at N-methyl-D-aspartate receptors in Xenopus oocytes. Neurosci. Lett. 225:1997;29-32.
160. 2+. Neuron. 15:1995;1109-1120.
161. Paoletti P., Ascher P., Neyton J. High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J. Neurosci. 17:1997;5711-5725.
162. Parsons C.G., Quack G., Bresink I., Baran L., Przegalinski E., Kostowski W., Krzascik P., Hartmann S., Danysz W. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology. 34:1995;1239-1258.
163. Parsons C.G., Panchenko V.A., Pinchenko V.O., Tsyndrenko A.Y., Krishtal O.A. Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine. Eur. J. Neurosci. 8:1996;446-454.
164. Petrou S., Ordway R.W., Singer J.J., Walsh J.V.J. A putative fatty acid-binding domain of the NMDA receptor. Trends Biochem. Sci. 18:1993;41-42.
165. Premkumar L.S., Auerbach A. Identification of a high affinity divalent cation binding site near the entrance of the NMDA receptor channel. Neuron. 16:1996;869-880.
166. Pud D., Eisenberg E., Spitzer A., Adler R., Fried G., Yarnitsky D. The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial. Pain. 75:1998;349-354.
167. Raman I.M., Tong G., Jahr C.E. β-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase. Neuron. 16:1996;415-421.
168. Reynolds I.J., Miller R.J. Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines. Mol. Pharmac. 36:1989;758-765.
169. 2+ fluxes. Br. J. Pharmac. 101:1990;178-182.
170. Rock D.M., Macdonald R.L. The polyamine spermine has multiple actions on N-methyl-D-aspartate receptor single-channel currents in cultured cortical neurons. Mol. Pharmac. 41:1992;83-88.
171. Rodriguez-Paz J.M., Anantharam V., Treistman S.N. Block of the N-methyl-D-aspartate receptor by phencyclidine-like drugs is influenced by alternative splicing. Neurosci. Lett. 190:1995;147-150.
172. Rosenmund C., Westbrook G.L. Calcium-induced actin depolymerization reduces NMDA channel activity. Neuron. 10:1993;805-814.
173. 2+ and ATP. J. Physiol. (Lond.). 470:1993;705-729.
174. Ruppersberg J.P., Mosbacher J., Günther W., Schoepfer R., Fakler B. Studying block in cloned N-methyl-D-aspartate (NMDA) receptors. Biochem. Pharmac. 46:1993;1877-1885.
175. Sakimura K., Kutsuwada T., Ito I., Manabe T., Takayama C., Kushiya E., Yagi T., Aizawa S., Inoue Y., Sugiyama H., Mishina M. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit. Nature. 373:1995;151-155.
176. 2+ and channel blockers by a single amino acid substitution in the N-methyl-D-aspartate receptor. J. biol. Chem. 268:1993;410-415.
177. Sather W., Johnson J.W., Henderson G., Ascher P. Glycine-insensitive desensitization of NMDA responses in cultured mouse embryonic neurons. Neuron. 4:1990;725-731.
178. Sather W., Dieudonne S., MacDonald J.F., Ascher P. Activation and desensitization of N-methyl-D-aspartate receptors in nucleated outside-out patches from mouse neurones. J. Physiol. (Lond.). 450:1992;643-672.
179. Scatton B. Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases. Life Sci. 55:1994;2115-2124.
180. Scatton B., Avenet P., Benavides J., Carter C., Duverger D., Oblin A., Perrault G., Sanger D.J., Schoemaker H. Neuroprotective potential of the polyamine site-directed NMDA receptor antagonists - ifenprodil and eliprodil. Palfreyman M.G., Reynolds I.J., Skolnick P. Direct and Allosteric Control of Glutamate Receptors. 1994;139-154 CRC Press, London.
181. Schwartz B.L., Hashtroudi S., Herting R.L., Schwartz P., Deutsch S.I. D-Cycloserine enhances implicit memory in Alzheimer patients. Neurology. 46:1996;420-424.
182. Seeburg P.H. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 16:1993;359-365.
183. Sharma G., Stevens C.F. Interactions between two divalent ion binding sites in N-methyl-D-aspartate receptor channels. Proc. Natl Acad. Sci. USA. 93:1996;14170-14175.
184. Sharma G., Stevens C.F. A mutation that alters magnesium block of N-methyl-D-aspartate receptor channels. Proc. Natl Acad. Sci. USA. 93:1996;9259-9263.
185. Sheng M., Cummings J., Roldan L.A., Jan Y.N., Jan L.Y. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature. 368:1994;144-147.
186. Sigel E., Baur R., Malherbe P. Protein kinase C transiently activated heteromeric N-methyl-D-aspartate receptor channels independent of the phosphorylatable C-terminal splice domain and of consensus phosphorylation sites. J. Biol. Chem. 269:1994;8204-8208.
187. Smart T.G., Xie X., Krishek B.J. Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc. Prog. Neurobiol. 42:1994;393-441.
188. Snell L.D., Tabakoff B., Hoffman P.L. Involvement of protein kinase C in ethanol-induced inhibition of NMDA receptor function in cerebellar granule cells. Alcohol. Clin. Exp. Res. 18:1994;81-85.
189. Soloviev M.M., Barnard E.A. Xenopus oocytes express a unitary glutamate receptor endogenously. J. Mol. Biol. 273:1997;14-18.
190. Soloviev M.M., Brierley M.J., Shao Z.Y., Mellor I.R., Volkova T.M., Kamboj R., Ishimaru H., Sudan H., Harris J., Foldes R.L., Grishin E.V., Usherwood P.N.R., Barnard E.A. Functional expression of a recombinant unitary glutamate receptor from Xenopus, which contains N-methyl-D-aspartate (NMDA) and non-NMDA receptor subunits. J. biol. Chem. 271:1996;32572-32579.
191. Sprengel R., Suchanek B., Amico C., Brusa R., Burnashev N., Rozov A., Hvalby Ø., Jensen V., Paulsen O., Andersen P., Kim J.J., Thompson R.F., Sun W., Webster L.C., Grant S.G., Eilers J., Konnerth A., Li J., McNamara J.O., Seeburg P.H. Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. Cell. 92:1998;279-289.
192. Stern-Bach Y., Bettler B., Hartley M., Sheppard P.O., O'Hara P.J., Heinemann S.F. Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acid-binding proteins. Neuron. 13:1994;1345-1357.
193. Stevens C.F. Spatial learning and memory: the beginning of a dream. Cell. 87:1996;1147-1148.
194. Suchanek B., Seeburg P.H., Sprengel R. Gene structure of the murine N-methyl-D-aspartate receptor subunit NR2C. J. Biol. Chem. 270:1995;41-44.
195. Sucher N.J., Akbarian S., Chi C.L., Leclerc C.L., Awobuluyi M., Deitcher D.L., Wu M.K., Yuan J.P., Jones E.G., Lipton S.A. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J. Neurosci. 15:1995;6509-6520.
196. Sucher N.J., Awobuluyi M., Choi Y.B., Lipton S.A. NMDA receptors: from genes to channels. Trends Pharmac. Sci. 17:1996;348-355.
197. Sugihara H., Moriyoshi K., Ishii T., Masu M., Nakanishi S. Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing. Biochem. Biophys. Res. Commun. 185:1992;826-832.
198. Sullivan J.M., Traynelis S.F., Chen H.S., Escobar W., Heinemann S.F., Lipton S.A. Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron. 13:1994;929-936.
199. Suzuki T., Okumura-Noji K. NMDA receptor subunits ε1 (NR2A) and ε2 (NR2B) are substrates for Fyn in the postsynaptic density fraction isolated from the rat brain. Biochem. Biophys. Res. Commun. 216:1995;582-588.
200. Tabuchi S., Kume K., Aihara M., Ishii S., Mishina M., Shimizu T. Lipid mediators modulate NMDA receptor currents in a Xenopus oocyte expression system. Neurosci. Lett. 237:1997;13-16.
201. Takahashi H., Miyazaki M., Nanbu T., Yanagida H., Morita S. The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case. Pain. 75:1998;391-394.
202. Tamura Y., Sato Y., Yokota T., Akaike A., Sasa M., Takaori S. Ifenprodil prevents glutamate cytotoxicity via polyamine modulatory sites of N-methyl-D-aspartate receptors in cultured cortical neurons. J. Pharmac. Exp. Ther. 265:1993;1017-1025.
203. +. Proc. Natl Acad. Sci. USA. 87:1990;6445-6449.
204. Thornberg S.A., Saklad S.R. A review of NMDA receptors and the phencyclidine model of schizophrenia. Pharmacotherapy. 16:1996;82-93.
205. Tingley W.G., Roche K.W., Thompson A.K., Huganir R.L. Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain. Nature. 364:1993;70-73.
206. Tingley W.G., Ehlers M.D., Kameyama K., Doherty C., Ptak J.B., Riley C.T., Huganir R.L. Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J. Biol. Chem. 272:1997;5157-5166.
207. Tong G., Jahr C.E. Regulation of glycine-insensitive desensitization of the NMDA receptor in outside-out patches. J. Neurophysiol. 72:1994;754-761.
208. Tong G., Shepherd D., Jahr C.E. Synaptic desensitization of NMDA receptors by calcineurin. Science. 267:1995;1510-1512.
209. Traynelis S.F., Cull-Candy S.G. Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons. Nature. 345:1990;347-350.
210. Traynelis S.F., Hartley M., Heinemann S.F. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science. 268:1995;873-876.
211. Traynelis S.F., Burgess M.F., Zheng F., Lyuboslavsky P., Powers J.L. Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit. J. Neurosci. 18:1998;6163-6175.
212. Tsien J.Z., Chen D.F., Gerber D., Tom C., Mercer E.H., Anderson D.J., Mayford M., Kandel E.R., Tonegawa S. Subregion- and cell type-restricted gene knockout in mouse brain. Cell. 87:1996;1317-1326.
213. Tsien J.Z., Huerta P.T., Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell. 87:1996;1327-1338.
214. Tölle T.R., Berthele A., Zieglgansberger W., Seeburg P.H., Wisden W. The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J. Neurosci. 13:1993;5009-5028.
215. Verdoorn T.A., Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Structural determinants of ion flow through recombinant glutamate receptor channels. Science. 252:1991;1715-1718.
216. Villarroel A., Burnashev N., Sakmann B. Dimensions of the narrow portion of a recombinant NMDA receptor channel. Biophys. J. 68:1995;866-875.
217. Villarroel A., Regalado M.P., Lerma J. Glycine-independent NMDA receptor desensitization: localization of structural determinants. Neuron. 20:1998;329-339.
218. Vyklicky L.J. Calcium-mediated modulation of N-methyl-D-aspartate (NMDA) responses in cultured rat hippocampal neurones. J. Physiol. (Lond.). 470:1993;575-600.
219. Vyklicky L.J., Benveniste M., Mayer M.L. Modulation of N-methyl-D-aspartic acid receptor desensitization by glycine in mouse cultured hippocampal neurones. J. Physiol. (Lond.). 428:1990;313-331.
220. Vyklicky L.J., Vlachova V., Krusek J. The effect of external pH changes on responses to excitatory amino acids in mouse hippocampal neurones. J. Physiol. (Lond.). 430:1990;497-517.
221. Wafford K.A., Bain C.J., Le Bourdelles B., Whiting P.J., Kemp J.A. Preferential co-assembly of recombinant NMDA receptors composed of three different subunits. Neuroreport. 4:1993;1347-1349.
222. Wafford K.A., Kathoria M., Bain C.J., Marshall G., Le Bourdelles B., Kemp J.A., Whiting P.J. Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site. Mol. Pharmac. 47:1995;374-380.
223. Wang L.Y., Orser B.A., Brautigan D.L., MacDonald J.F. Regulation of NMDA receptors in cultured hippocampal neurons by protein phosphatases 1 and 2A. Nature. 369:1994;230-232.
224. Wang Y.T., Salter M.W. Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature. 369:1994;233-235.
225. 2+-independent reduction of N-methyl-D-aspartate channel activity by protein tyrosine phosphatase. Proc. Natl Acad. Sci. USA. 93:1996;1721-1725.
226. Watanabe M., Inoue Y., Sakimura K., Mishina M. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport. 3:1992;1138-1140.
227. Watanabe M., Inoue Y., Sakimura K., Mishina M. Distinct distributions of five N-methyl-D-aspartate receptor channel subunit mRNAs in the forebrain. J. comp. Neurol. 338:1993;377-390.
228. Watanabe M., Mishina M., Inoue Y. Distinct distributions of five NMDA receptor channel subunit mRNAs in the brainstem. J. Comp. Neurol. 343:1994;520-531.
229. Watanabe M., Mishina M., Inoue Y. Distinct spatiotemporal distributions of the N-methyl-D-aspartate receptor channel subunit mRNAs in the mouse cervical cord. J. Comp. Neurol. 345:1994;314-319.
230. Watanabe M., Mishina M., Inoue Y. Distinct spatiotemporal expressions of five NMDA receptor channel subunit mRNAs in the cerebellum. J. Comp. Neurol. 343:1994;513-519.
231. Whetsell W.O.J. Current concepts of excitotoxicity. J. Neuropathol. Exp. Neurol. 55:1996;1-13.
232. Whittemore E.R., Ilyin V.I., Konkoy C.S., Woodward R.M. Subtype-selective antagonism of NMDA receptors by nylidrin. Eur. J. Pharmac. 337:1997;197-208.
233. Whittemore E.R., Ilyin V.I., Woodward R.M. Antagonism of N-methyl-D-aspartate receptors by σ site ligands: potency, subtype-selectivity and mechanisms of inhibition. J. Pharmac. Exp. Ther. 282:1997;326-338.
234. Williams K. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmac. 44:1993;851-859.
235. Williams K. Mechanisms influencing stimulatory effects of spermine at recombinant N-methyl-D-aspartate receptors. Mol. Pharmac. 46:1994;161-168.
236. Williams K. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine. Mol. Pharmac. 46:1994;531-541.
237. Williams K. Pharmacological properties of recombinant N-methyl-D-aspartate (NMDA) receptors containing the ε4 (NR2D) subunit. Neurosci. Lett. 184:1995;181-184.
238. Williams K. Separating dual effects of zinc at recombinant N-methyl-D-aspartate receptors. Neurosci. Lett. 215:1996;9-12.
239. Williams K. Interactions of polyamines with ion channels. Biochem. J. 325:1997;289-297.
240. Williams K., Russell S.L., Shen Y.M., Molinoff P.B. Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron. 10:1993;267-278.
241. Williams K., Zappia A.M., Pritchett D.B., Shen Y.M., Molinoff P.B. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Mol. Pharmac. 45:1994;803-809.
242. Williams K., Kashiwagi K., Fukuchi J., Igarashi K. An acidic amino acid in the N-methyl-D-aspartate receptor that is important for spermine stimulation. Mol. Pharmac. 48:1995;1087-1098.
243. Williams K., Chao J., Kashiwagi K., Masuko T., Igarashi K. Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit. Mol. Pharmac. 50:1996;701-708.
244. 2+. Mol. Pharmac. 53:1998;933-941.
245. Wo Z.G., Oswald R.E. Transmembrane topology of two kainate receptor subunits revealed by N-glycosylation. Proc. Natl Acad. Sci. USA. 91:1994;7154-7158.
246. Wo Z.G., Oswald R.E. A topological analysis of goldfish kainate receptors predicts three transmembrane segments. J. Biol. Chem. 270:1995;2000-2009.
247. Wo Z.G., Oswald R.E. Unraveling the modular design of glutamate-gated ion channels. Trends Neurosci. 18:1995;161-168.
248. Wollmuth L.P., Kuner T., Seeburg P.H., Sakmann B. Differential contribution of the NR1- and NR2A-subunits to the selectivity filter of recombinant NMDA receptor channels. J. Physiol. (Lond.). 491:1996;779-797.
249. 2+. J. Physiol. (Lond.). 506:1998;13-32.
250. 2+ interacts with structural determinants of the narrow constriction contributed by the NR1-subunit in the NMDA receptor channel. J. Physiol. (Lond.). 506:1998;33-52.
251. Wood M.W., VanDongen H.M.A., VanDongen A.M.J. Structural conservation of ion conduction pathways in K channels and glutamate receptors. Proc. natl Acad. Sci. USA. 92:1995;4882-4886.
252. Wood M.W., VanDongen H.M.A., VanDongen A.M.J. An alanine residue in the M3-M4 linker lines the glycine binding pocket of the N-methyl-D-aspartate receptor. J. biol. Chem. 272:1997;3532-3537.
253. Woolf C.J. Windup and central sensitization are not equivalent. Pain. 66:1996;105-108.
254. Woolf C.J., Thompson S.W.N. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-299.
255. Wyszynski M., Lin J., Rao A., Nigh E., Beggs A.H., Craig A.M., Sheng M. Competitive binding of α-actinin and calmodulin to the NMDA receptor. Nature. 385:1997;439-442.
256. Yamakura T., Mori H., Masaki H., Shimoji K., Mishina M. Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists. Neuroreport. 4:1993;687-690.
257. Yamakura T., Mori H., Shimoji K., Mishina M. Phosphorylation of the carboxyl-terminal domain of the ζ1 subunit is not responsible for potentiation by TPA of the NMDA receptor channel. Biochem. biophys. Res. Commun. 196:1993;1537-1544.
258. Yamakura T., Sakimura K., Mishina M., Shimoji K. The sensitivity of AMPA-selective glutamate receptor channels to pentobarbital is determined by a single amino acid residue of the α2 subunit. FEBS Lett. 374:1995;412-414.
259. Yamakura T., Sakimura K., Shimoji K., Mishina M. Effects of propofol on various AMPA-, kainate- and NMDA-selective glutamate receptor channels expressed in Xenopus oocytes. Neurosci. Lett. 188:1995;187-190.
260. Yamakura T., Sakimura K., Mishina M., Shimoji K. Sensitivity of the N-methyl-D-aspartate receptor channel to butyrophenones is dependent on the ε2 subunit. Neuropharmacology. 37:1998;709-717.
261. Yamazaki M., Mori H., Araki K., Mori K.J., Mishina M. Cloning, expression and modulation of a mouse NMDA receptor subunit. FEBS Lett. 300:1992;39-45.
262. Yu X.M., Askalan R., Keil G.J.n., Salter M.W. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science. 275:1997;674-678.
263. Zarei M.M., Dani J.A. Structural basis for explaining open-channel blockade of the NMDA receptor. J. Neurosci. 15:1995;1446-1454.
264. Zhang L., Zheng X., Paupard M.C., Wang A.P., Santchi L., Friedman L.K., Zukin R.S., Bennett M.V. Spermine potentiation of recombinant N-methyl-D-aspartate receptors is affected by subunit composition. Proc. Natl Acad. Sci. USA. 91:1994;10883-10887.
265. Zheng F., Gingrich M.B., Traynelis S.F., Conn P.J. Tyrosine kinase potentiates NMDA receptor currents by reducing tonic zinc inhibition. Nature Neurosci. 1:1998;185-191.
266. 2+ potentiation of recombinant NMDA receptors. Neuron. 12:1994;811-818.
267. 2+ influx amplifies protein kinase C potentiation of recombinant NMDA receptors. J. Neurosci. 17:1997;8676-8686.
268. Zukin R.S., Bennett M.V. Alternatively spliced isoforms of the NMDAR1 receptor subunit. Trends Neurosci. 18:1995;306-313.